Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jack Lee

Showing results (351-360 of 594) with videos related to

Pageof 60
Sort By:
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Molecular Cancer|June 5, 2015
Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancerHye-Young Min, Hye Jeong Yun, Ji-Sun Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Mortality risk from squamous cell skin cancerGary L Clayman, J Jack Lee, F Christopher Holsinger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsAnne S Tsao, Diane Liu, Jack Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancerJunya Fujimoto, Humam Kadara, Melinda M Garcia, et al.
Annals of Surgical Oncology|May 29, 2009
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin CLaura A Lambert, Terri S Armstrong, J Jack Lee, et al.
Artery Research|September 5, 2014
Enhancing coronary Wave Intensity Analysis robustness by high order central finite differencesSimone Rivolo, Kaleab N Asrress, Amedeo Chiribiri, et al.
Clinical Lung Cancer|April 28, 2006
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access programSheeba K Thomas, Frank V Fossella, Diane Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancerEmer O Hanrahan, Heather Y Lin, Edward S Kim, et al.
Plos One|February 24, 2023
An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysisGrace Lui, Ho Sang Leung, Jack Lee, et al.
Pageof 60

Showing results (351-360 of 594) with videos related to

Sort By:
Pageof 60
NPJ Precision Oncology|October 28, 2021
An analysis of research biopsy core variability from over 5000 prospectively collected core samplesDeepak Bhamidipati, Anuj Verma, Dawen Sui, et al.
Molecular Cancer|June 5, 2015
Targeting the insulin-like growth factor receptor and Src signaling network for the treatment of non-small cell lung cancerHye-Young Min, Hye Jeong Yun, Ji-Sun Lee, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 1, 2005
Mortality risk from squamous cell skin cancerGary L Clayman, J Jack Lee, F Christopher Holsinger, et al.
Cancer Prevention Research (Philadelphia, Pa.)|November 7, 2009
Phase II randomized, placebo-controlled trial of green tea extract in patients with high-risk oral premalignant lesionsAnne S Tsao, Diane Liu, Jack Martin, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer|November 17, 2012
G-protein coupled receptor family C, group 5, member A (GPRC5A) expression is decreased in the adjacent field and normal bronchial epithelia of patients with chronic obstructive pulmonary disease and non-small-cell lung cancerJunya Fujimoto, Humam Kadara, Melinda M Garcia, et al.
Annals of Surgical Oncology|May 29, 2009
Incidence, risk factors, and impact of severe neutropenia after hyperthermic intraperitoneal mitomycin CLaura A Lambert, Terri S Armstrong, J Jack Lee, et al.
Artery Research|September 5, 2014
Enhancing coronary Wave Intensity Analysis robustness by high order central finite differencesSimone Rivolo, Kaleab N Asrress, Amedeo Chiribiri, et al.
Clinical Lung Cancer|April 28, 2006
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access programSheeba K Thomas, Frank V Fossella, Diane Liu, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 2, 2009
Distinct patterns of cytokine and angiogenic factor modulation and markers of benefit for vandetanib and/or chemotherapy in patients with non-small-cell lung cancerEmer O Hanrahan, Heather Y Lin, Edward S Kim, et al.
Plos One|February 24, 2023
An efficient approach to estimate the risk of coronary artery disease for people living with HIV using machine-learning-based retinal image analysisGrace Lui, Ho Sang Leung, Jack Lee, et al.
Pageof 60